Real‐world analysis of patients with haemophilia A and haemophilia A carriers in the United States: Demographics, clinical characteristics and costs
Open Access
- 6 May 2023
- journal article
- research article
- Published by Wiley in Haemophilia
- Vol. 29 (3) , 809-818
Abstract
IntroductionFemales with haemophilia A (HA [FHAs]) and HA carriers (HACs) have an increased risk of bleeding and complications compared to the general population. AimTo examine the characteristics, billed annualised bleed rates (ABR(b)), costs and healthcare resource utilisation for males with HA (MHAs), FHAs and HACs in the United States. MethodsData were extracted from the IBM (R) MarketScan (R) Research Databases (Commercial and Medicaid) for claims during the index period (July 2016 to September 2018) and analysed across MHAs, FHAs and HACs. ResultsDual diagnosis females (DDFs; both HA and HAC claims) were grouped as a separate cohort. MHAs were generally younger than females (all cohorts) by up to 19 years (Commercial) and 23 years (Medicaid). ABR(b) >0 was more frequent in females. Factor VIII claims were higher for MHAs versus female cohorts. Joint-related health issues were reported for 24.4 and 25.6% (Commercial) and 29.3 and 26.6% (Medicaid) of MHAs and FHAs, respectively; lower rates were reported in the other two cohorts. Heavy menstrual bleeding claims occurred for approximately a fifth (Commercial) to a quarter (Medicaid) of female cohorts. All-cause emergency department and inpatient visits in FHAs and DDFs were similar to, or more frequent than, those in MHAs; bleed-related inpatient visits were infrequent. In MHAs (Commercial), mean all-cause total costs ($214,083) were higher than in FHAs ($40,388), HACs ($15,647) and DDFs ($28,320) with similar trends for Medicaid patients. ConclusionsFHAs and HACs may be undermanaged and undertreated. Further research is needed to fully understand these cohorts' bleeding rates, long-term complications and costs.Keywords
This publication has 31 references indexed in Scilit:
- Improving care and treatment options for women and girls with bleeding disordersEuropean Journal of Haematology, 2015
- A cross‐sectional study of bleeding phenotype in haemophilia A carriersBritish Journal of Haematology, 2015
- Definitions in hemophilia: communication from the SSC of the ISTHJournal of Thrombosis and Haemostasis, 2014
- Values and Pitfalls of the Use of Administrative Databases for Outcomes AssessmentJournal of Urology, 2013
- Evaluation of bleeding disorders in women with menorrhagia: a survey of obstetrician-gynecologistsAmerican Journal of Obstetrics and Gynecology, 2012
- How many carriers are there?Haemophilia, 2010
- Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panelAmerican Journal of Obstetrics and Gynecology, 2009
- Sex Differences in Osteoarthritis of the Hip and KneeJournal of the American Academy of Orthopaedic Surgeons, 2007
- Bleeding in carriers of hemophiliaBlood, 2006
- A longitudinal study of orthopaedic outcomes for severe factor‐VIII‐deficient haemophiliacsJournal of Internal Medicine, 1994